Plus Therapeutics Inc (NASDAQ: PSTV) is -68.03% lower on its value in year-to-date trading and has touched a low of $0.24 and a high of $2.67 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PSTV stock was last observed hovering at around $0.29 in the last trading session, with the day’s gains setting it 0.08%.
Currently trading at $0.37, the stock is -17.08% and -48.20% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 162.08 million and changing 28.16% at the moment leaves the stock -67.25% off its SMA200. PSTV registered -82.66% loss for a year compared to 6-month loss of -71.27%. The firm has a 50-day simple moving average (SMA 50) of $0.7302 and a 200-day simple moving average (SMA200) of $1.12845.
The stock witnessed a -43.44% gain in the last 1 month and extending the period to 3 months gives it a -44.29%, and is 22.98% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.46% over the week and 12.90% over the month.
Plus Therapeutics Inc (PSTV) has around 21 employees, a market worth around $6.25M and $5.21M in sales. Profit margin for the company is -520.90%. Distance from 52-week low is 53.21% and -86.23% from its 52-week high.
The EPS is expected to grow by 57.69% this year.
Plus Therapeutics Inc (PSTV) Top Institutional Holders
17.0 institutions hold shares in Plus Therapeutics Inc (PSTV), with institutional investors hold 9.13% of the company’s shares. The shares outstanding are 17.00M, and float is at 15.49M with Short Float at 22.53%. Institutions hold 7.50% of the Float.
The top institutional shareholder in the company is AIGH CAPITAL MANAGEMENT LLC with over 0.57 million shares valued at $0.84 million. The investor’s holdings represent 8.7478% of the PSTV Shares outstanding.
Plus Therapeutics Inc (PSTV) Insider Activity
#####
Plus Therapeutics Inc disclosed in a document filed with the SEC on Sep 13 ’24 that Hawkins Richard J (Director) bought a total of 4,000 shares of the company’s common stock. The trade occurred on Sep 13 ’24 and was made at $1.50 per share for $5996.0. Following the transaction, the insider now directly holds 15188.0 shares of the PSTV stock.
Still, SEC filings show that on Sep 12 ’24, Hawkins Richard J (Director) acquired 6,285 shares at an average price of $1.35 for $8512.0. The insider now directly holds 11,188 shares of Plus Therapeutics Inc (PSTV).
